Laboratory research materials for in vitro use only.

Sermorelin

For laboratory research use only (in vitro). Not for human or animal use.

Price range: $74.99 through $90.99

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$69.99
3-4 units5% off$66.49
5-9 units10% off$62.99
10+ units Best Value15% off$59.49

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

InteracVisaMCCrypto

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence YADAIFTNSY RKVLGQLSAR KLLQDIMSR-NH2
Molecular Weight 3357.88 Da
Molecular Formula C149H246N44O42S
CAS Number 86168-78-7
Purity ≥98% (HPLC)
Format Lyophilized Powder
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Approved

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

Sermorelin analytical reference compound. Molecular weight 3357.88 Da.

Specifications

Sequence YADAIFTNSY RKVLGQLSAR KLLQDIMSR-NH2
Molecular Weight 3357.88 Da
Molecular Formula C149H246N44O42S
CAS 86168-78-7
Purity >=98% (HPLC)
Format Lyophilized powder
Storage Store at -20C. Reconstituted: 2-8C

For laboratory research use only (in vitro). Not for human or animal use.

Additional information

Size

5mg, 10mg

Published Research

5 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?

Walker RF (2006). Clinical Interventions in Aging. PubMed 18046908

Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency

Prakash A, Goa KL (1999). BioDrugs. PubMed 18031173

Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

Vittone J, Blackman MR, Busby-Whitehead J, et al. (1997). Journal of Clinical Endocrinology and Metabolism. PubMed 9005976

Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity

Lanes R, Carrillo E, Villaroel O, Moncada G (1993). Journal of Pediatric Endocrinology. PubMed 7955460

Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males

Siebert DM, Rao AL (2020). Translational Andrology and Urology. PubMed 32257855

For laboratory research use only (in vitro). Not for human or animal use.

Age Verification Required

You must be 19 years of age or older to access this website. This site contains laboratory research materials restricted to qualified personnel.